California State Teachers Retirement System (CalSTRS)
SANA icon

California State Teachers Retirement System (CalSTRS)’s Sana Biotechnology SANA Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634K Buy
181,749
+18,190
+11% +$58.6K ﹤0.01% 2106
2026
Q1 		$471K Sell
163,559
-1,232
-0.7% -$4.85K ﹤0.01% 2082
2025
Q4 		$671K Buy
164,791
+36,115
+28% +$162K ﹤0.01% 1968
2025
Q3 		$457K Buy
128,676
+119,097
+1,243% +$431K ﹤0.01% 2125
2025
Q2 		$26.2K Sell
9,579
-105,455
-92% -$218K ﹤0.01% 2421
2025
Q1 		$193K Hold
115,034
– – ﹤0.01% 2306
2024
Q4 		$188K Sell
115,034
-897
-0.8% -$2.67K ﹤0.01% 2351
2024
Q3 		$482K Sell
115,931
-13,345
-10% -$70.1K ﹤0.01% 2141
2024
Q2 		$706K Buy
129,276
+30,997
+32% +$247K ﹤0.01% 1926
2024
Q1 		$983K Sell
98,279
-5,148
-5% -$38.6K ﹤0.01% 1804
2023
Q4 		$422K Buy
103,427
+6,694
+7% +$24.7K ﹤0.01% 2291
2023
Q3 		$374K Sell
96,733
-10,037
-9% -$53.9K ﹤0.01% 2338
2023
Q2 		$636K Sell
106,770
-1,722
-2% -$9.92K ﹤0.01% 2179
2023
Q1 		$355K Sell
108,492
-1,395
-1% -$5.57K ﹤0.01% 2453
2022
Q4 		$434K Buy
109,887
+1,312
+1% +$6.42K ﹤0.01% 2404
2022
Q3 		$651K Sell
108,575
-1,518
-1% -$11K ﹤0.01% 2199
2022
Q2 		$708K Buy
110,093
+41,194
+60% +$262K ﹤0.01% 2183
2022
Q1 		$569K Sell
68,899
-9,487
-12% -$76.7K ﹤0.01% 2349
2021
Q4 		$1.21M Buy
78,386
+31,734
+68% +$612K ﹤0.01% 2043
2021
Q3 		$1.05M Buy
46,652
+9,625
+26% +$202K ﹤0.01% 2120
2021
Q2 		$728K Sell
37,027
-10,313
-22% -$234K ﹤0.01% 2417
2021
Q1 		$1.58M Buy
+47,340
New +$1.54M ﹤0.01% 1877

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marex Group
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s SANA Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Sana Biotechnology (SANA) stake by 11% in Q2 2026, buying an estimated $58.6K and bringing the position to 181,749 shares worth $634K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

California State Teachers Retirement System (CalSTRS) first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.58M in Q1 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 181,749 shares of Sana Biotechnology worth $634K as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) bought 18,190 Sana Biotechnology shares in Q2 2026, an estimated $58.6K.
  • Sana Biotechnology made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2106 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Sana Biotechnology position peaked at $1.58M in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.